Gadia, Viviano S.

HRN: 23-28-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
FLUCONAZOLE 150MG (CAP)
07/04/2023
07/06/2023
PO
150mg
OD
Sepsis Secondary To Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamDisseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: